Last deal

$14M

Amount

Series A

Stage

25.07.2016

Date

2

all rounds

$29M

Total amount

date founded

Financing round

General

About Company
Just - Evotec Biologics uses AI/ML and molecular design to accelerate biotherapeutic development.

Industry

Sector :

Subsector :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company integrates scientific expertise and machine learning to design and manufacture biologics more efficiently, reducing costs and accelerating the development process. Just - Evotec Biologics focuses on antibody discovery, molecular design, and manufacturing plant design, with the goal of expanding access to biotherapeutics through technological innovation. Founded in 2014 and acquired by Evotec in 2019, the company aims to revolutionize the biotherapeutics industry by leveraging AI/ML technologies and advanced molecular design.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Hangzhou Just Biotherapeutics (Just China)

Hangzhou Just Biotherapeutics (Just China)

Hangzhou Just Biotherapeutics is a high-tech design company that accelerates the development of bio-medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Life Science

Location

Hangzhou, Zhejiang, China

total rounds

5

total raised

$147.62M
Wayfinder Biosciences

Wayfinder Biosciences

Wayfinder Biosciences develops RNA technologies for sustainable biomanufacturing.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Life Science

Location

San Francisco, CA, USA

total rounds

6

total raised

$4M
Sunflower Therapeutics

Sunflower Therapeutics

Sunflower Therapeutics is a biotech startup focused on developing and manufacturing biologics for global patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Manufacturing

Location

Weymouth, MA, USA

total rounds

3

total raised

$10.1M
Hamol Biosolutions

Hamol Biosolutions

Design, development and manufacture of peptide based biologic therapeutics

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Medical

Location

San Diego, CA, USA
M&A Details
1

Transaction name

Acquired by

Evotec

announced date

20.05.2019

price

$90M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$29M

Money Raised

Their latest funding was raised on 25.07.2016. Their latest investor ARCH Venture Partners. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Lilly Asia Ventures

Lilly Asia Ventures

Lilly Asia Ventures is a venture capital firm that invests in life sciences and healthcare companies in Asia, particularly China.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Shanghai, China

count Of Investments

165

count Of Exists

11
ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that specializes in investing in early-stage technology companies in the United States.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Chicago, IL, USA

count Of Investments

358

count Of Exists

61
Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation is a philanthropic organization.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit

Location

New York, NY, USA

count Of Investments

283

count Of Exists

13
Merck Sharp & Dohme Sweden AB

Merck Sharp & Dohme Sweden AB

Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kenilworth, NJ, USA

total rounds

2

total raised

$5.59M

count Of Investments

21

count Of Exists

4
Co-Investors
Investors
4
4

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that specializes in investing in early-stage technology companies in the United States.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Chicago, IL, USA

count Of Investments

358

count Of Exists

61
Lilly Asia Ventures

Lilly Asia Ventures

Lilly Asia Ventures is a venture capital firm that invests in life sciences and healthcare companies in Asia, particularly China.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Shanghai, China

count Of Investments

165

count Of Exists

11
Merck Sharp & Dohme Sweden AB

Merck Sharp & Dohme Sweden AB

Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kenilworth, NJ, USA

total rounds

2

total raised

$5.59M

count Of Investments

21

count Of Exists

4

People

Founders
3
Victor P. Fung
Victor P. Fung

Victor P. Fung

As founding partner and COO of Just, Victor brings over 30 years of biotechnology industry experience that includes executive level accountability for biopharmaceutical process development, manufacturing and operations. During his tenure at Amgen, Victor was site head for Process and Analytical Sciences in Seattle, Washington and global leader for Pilot Plant Operations and Cellular Resources across three locations. He managed diverse scientific disciplines such as cell culture process development, purification process development, analytical sciences, pilot plant operations, cell banking, nucleic acid chemistry, bioassay, biosafety and critical reagents. Victor worked at Genentech Inc., Immunex Corporation and Targeted Genetics and has contributed to the commercialization of biopharmaceuticals such as Activase®, Pulmozyme®, Enbrel® and Vectibix®. In his most recent position, Victor was accountable for the development and commercialization of Amgen’s biosimilars portfolio. Victor was called upon to lead technology and business initiatives that transformed how molecules were designed and manufactured. He helped to create process development capabilities for the newly formed Biosimilars business unit within Amgen. These responsibilities reinforced the importance of developing strong strategic partnerships both internally and externally. Partnerships will be critical and foundational to success.

current job

Just - Evotec Biologics
Just - Evotec Biologics

organization founded

1

Victor P. Fung

Dean K. Pettit
Dean K. Pettit

Dean K. Pettit

As founding partner and CSO at Just Biotherapeutics, Dean brings a broad scientific background, and a deep commitment to advancing innovative technologies and challenging the industry to improve worldwide access to protein therapeutics. Over his career, Dean has held numerous leadership roles in process development functions at Immunex, Amgen, and Just including Drug Delivery, Formulation, Analytical and Formulation Sciences, and Drug Substance Development including Cell Culture and Cell Line Development, Purification, Analytical, and Bio-characterization functions. Dean played a key role in the development of a concept known as Product Attribute Control (PAC) that aims to actively measure the attributes of biopharmaceuticals during manufacturing and provide real time process control. Dean began his career working with medical devices at Allergan and then earned his Ph.D. and completed a postdoctoral fellowship in Protein Engineering at the University of Washington Department of Bioengineering.

current job

Just - Evotec Biologics
Just - Evotec Biologics

organization founded

1

Dean K. Pettit

James N. Thomas, Ph.D.
James N. Thomas, Ph.D.

James N. Thomas, Ph.D.

current job

Just - Evotec Biologics
Just - Evotec Biologics

organization founded

1

James N. Thomas, Ph.D.

Employee Profiles
26
Ryan Luce

Ryan Luce

Senior Program Manager, Software Operations

Magnus Schroeder

Magnus Schroeder

Vice President Process & Product Design

Dean K. Pettit

Dean K. Pettit

SVP Biotherapeutic Science

Victor P. Fung

Victor P. Fung

SVP Biotherapeutics

Jenna George

Downstream engineer

Richard Rogers

Principal scientist

James Lagasse

Scientist ii

Jeremy Shaver

Principal scientist, data science and molecular design

Activity

Recent News
0